Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver - PubMed (original) (raw)
Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver
L G Guidotti et al. Proc Natl Acad Sci U S A. 1996.
Abstract
Hepatitis B virus (HBV) infection is thought to be controlled by virus-specific cytotoxic T lymphocytes (CTL). We have recently shown that HBV-specific CTL can abolish HBV replication noncytopathically in the liver of transgenic mice by secreting tumor necrosis factor alpha (TNF-alpha) and interferon gamma (IFN-gamma) after antigen recognition. We now demonstrate that hepatocellular HBV replication is also abolished noncytopathically during lymphocytic choriomeningitis virus (LCMV) infection, and we show that this process is mediated by TNF-alpha and IFN-alpha/beta produced by LCMV-infected hepatic macrophages. These results confirm the ability of these inflammatory cytokines to abolish HBV replication; they elucidate the mechanism likely to be responsible for clearance of HBV in chronically infected patients who become superinfected by other hepatotropic viruses; they suggest that pharmacological activation of intrahepatic macrophages may have therapeutic value in chronic HBV infection; and they raise the possibility that conceptually similar events may be operative in other viral infections as well.
Similar articles
- Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice.
Guidotti LG, McClary H, Loudis JM, Chisari FV. Guidotti LG, et al. J Exp Med. 2000 Apr 3;191(7):1247-52. doi: 10.1084/jem.191.7.1247. J Exp Med. 2000. PMID: 10748242 Free PMC article. - Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.
McClary H, Koch R, Chisari FV, Guidotti LG. McClary H, et al. J Virol. 2000 Mar;74(5):2255-64. doi: 10.1128/jvi.74.5.2255-2264.2000. J Virol. 2000. PMID: 10666256 Free PMC article. - Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte.
Guidotti LG, Borrow P, Brown A, McClary H, Koch R, Chisari FV. Guidotti LG, et al. J Exp Med. 1999 May 17;189(10):1555-64. doi: 10.1084/jem.189.10.1555. J Exp Med. 1999. PMID: 10330434 Free PMC article. - Hepatitis B virus immunopathogenesis.
Chisari FV, Ferrari C. Chisari FV, et al. Annu Rev Immunol. 1995;13:29-60. doi: 10.1146/annurev.iy.13.040195.000333. Annu Rev Immunol. 1995. PMID: 7612225 Review. - Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis.
Chisari FV. Chisari FV. Curr Top Microbiol Immunol. 1996;206:149-73. doi: 10.1007/978-3-642-85208-4_9. Curr Top Microbiol Immunol. 1996. PMID: 8608715 Review.
Cited by
- Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.
Jost S, Turelli P, Mangeat B, Protzer U, Trono D. Jost S, et al. J Virol. 2007 Oct;81(19):10588-96. doi: 10.1128/JVI.02489-06. Epub 2007 Jul 25. J Virol. 2007. PMID: 17652382 Free PMC article. - Differential inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by the small heterodimer partner.
Oropeza CE, Li L, McLachlan A. Oropeza CE, et al. J Virol. 2008 Apr;82(8):3814-21. doi: 10.1128/JVI.02507-07. Epub 2008 Jan 30. J Virol. 2008. PMID: 18234786 Free PMC article. - Combinatorial RNA Interference Therapy Prevents Selection of Pre-existing HBV Variants in Human Liver Chimeric Mice.
Shih YM, Sun CP, Chou HH, Wu TH, Chen CC, Wu PY, Enya Chen YC, Bissig KD, Tao MH. Shih YM, et al. Sci Rep. 2015 Oct 20;5:15259. doi: 10.1038/srep15259. Sci Rep. 2015. PMID: 26482836 Free PMC article. - Fighting fire with fire: using infectious agents to treat persistent infection.
Albukhari M, Bagies M, Lizbeth T, Kottilil S. Albukhari M, et al. Future Microbiol. 2024 Sep;19(13):1177-1184. doi: 10.1080/17460913.2024.2363728. Epub 2024 Aug 6. Future Microbiol. 2024. PMID: 39105632 Review. - Gamma interferon is a major suppressive factor produced by activated human peripheral blood lymphocytes that is able to inhibit foamy virus-induced cytopathic effects.
Falcone V, Schweizer M, Toniolo A, Neumann-Haefelin D, Meyerhans A. Falcone V, et al. J Virol. 1999 Feb;73(2):1724-8. doi: 10.1128/JVI.73.2.1724-1728.1999. J Virol. 1999. PMID: 9882388 Free PMC article.
References
- J Exp Med. 1976 Nov 2;144(5):1305-15 - PubMed
- Immunity. 1996 Jan;4(1):25-36 - PubMed
- Eur J Immunol. 1981 Oct;11(10):805-15 - PubMed
- Proc Natl Acad Sci U S A. 1983 Apr;80(7):1910-4 - PubMed
- J Gen Virol. 1983 Aug;64 (Pt 8):1689-98 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources